These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 9116614

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
    Buckstein R, Imrie K, Spaner D, Potichnyj A, Robinson JB, Nanji S, Pennel N, Reis M, Pinkerton P, Dubé I, Hewitt K, Berinstein NL.
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):115-22. PubMed ID: 10561026
    [Abstract] [Full Text] [Related]

  • 23. Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (>/=60 years) with non-Hodgkin's lymphoma: comparison with patients <60 years treated within the same protocol.
    Jantunen E, Mahlamäki E, Nousiainen T.
    Bone Marrow Transplant; 2000 Oct; 26(7):737-41. PubMed ID: 11042654
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Fas-FasL-mediated CD4+ T-cell apoptosis following stem cell transplantation.
    Singh RK, Varney ML, Buyukberber S, Ino K, Ageitos AG, Reed E, Tarantolo S, Talmadge JE.
    Cancer Res; 1999 Jul 01; 59(13):3107-11. PubMed ID: 10397252
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Poor lymphocyte recovery following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Diviné M, Boutolleau D, Delfau-Larue MH, Beaujean F, Jouault H, Reyes F, Kuentz M, Bensussan A, Farcet JP, Boumsell L.
    Br J Haematol; 1999 May 01; 105(2):349-60. PubMed ID: 10233403
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation].
    Parra C, Roldán E, Rodríguez C, Pérez de Oteyza J, Oteho E, López J, Maldonado MS, García Laraña J, Muñoz A, Odriozola J, Brieva JA.
    Med Clin (Barc); 1999 Jun 12; 113(1):1-5. PubMed ID: 10422068
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Use of peripheral blood stem cells to accelerate hemopoietic recovery following autologous bone marrow transplantation.
    Tarella C, Gavarotti P, Caracciolo D, Locatelli F, Falda M, Paolino F, Lovisone E, Sormano E, Tassi V, Urgesi A.
    Haematologica; 1990 Jun 12; 75 Suppl 1():90-4. PubMed ID: 1972137
    [Abstract] [Full Text] [Related]

  • 34. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G, Lemoli R, Tosi P, Martinelli G, Testoni N, Ricci P, Motta M, Gherlinzoni F, Leopardi G, Pastano R, Rizzi S, Piccaluga P, Isidori A, Tura S.
    Bone Marrow Transplant; 1999 Sep 12; 24(5):467-72. PubMed ID: 10482929
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [A multicenter early phase II study of high-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of intermediate-grade non-Hodgkin's lymphoma. Japan Blood Cell Transplantation Study Group].
    Chou T, Ishiguro T, Imajo K, Kawano F, Gondo H, Kasai M, Masuda M, Koike M, Shimazaki C, Hara M, Shinagawa K, Ogawa M, Takaku F, Harada M.
    Rinsho Ketsueki; 1999 Oct 12; 40(10):1058-67. PubMed ID: 10565222
    [Abstract] [Full Text] [Related]

  • 37. [Therapy of highly malignant non-Hodgkin lymphoma with high-dose chemotherapy and stem cell transplantation].
    Schmitz N.
    Praxis (Bern 1994); 1998 Jun 24; 87(25-26):863-8. PubMed ID: 9702088
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D, Cao Y, Luetkens T, Panse J, Faltz C, Arfsten J, Bartels K, Wolschke C, Eiermann T, Zander AR, Fehse B, Bokemeyer C, Kroger N.
    Haematologica; 2008 Mar 24; 93(3):423-30. PubMed ID: 18287134
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.